Dr. Alexander Hirsch and Dr. C. Michael Gibson discuss: Addition of Computed Tomography-derived Fractional Flow Reserve in the diagnostic pathway of patients with stable coronary artery disease: the FUSION randomized trial August 28, 2026 2026 | ESC | Slides | Trial | Video Hirsch_FUSION_LateBreaking_Aug28_ESC2026Download Sponsored by Heartflow Article Navigation Dr. Dan Judge and Dr. C. Michael Gibson discuss new findings from a study evaluating the differential stabilization of transthyretin (TTR) with acoramidis and tafamidis. The study found greater TTR stabilization with acoramidis across multiple analyses, including in vitro testing of 51 patient samples representing 17 unique TTR variants. Dr. Boyoung Joung and Dr. C. Michael Gibson discuss: SINGLE-AF: Anticoagulation for atrial fibrillation with intermediate stroke risk
